top of page
The Way Forward Is Clearer, Together.
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Search
Women's Cancer Research Foundation
Oct 14, 20211 min read
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
For the past ten yrs, continued use of bevacizumab therapy in the first-line treatment of ovarian cancer has reportedly improved...
0 comments
Women's Cancer Research Foundation
Oct 12, 20211 min read
Risk of Late-Onset Breast Cancer in Genetically Predisposed Women
Germline mutations in breast cancer predispose women to develop this malignancy, but in woman 65+years, the risk is not well-defined.
0 comments
Women's Cancer Research Foundation
Oct 8, 20211 min read
Combination Strategies Reshape Treatment Paradigm for Advanced Endometrial Cancer
Initially, pembrolizumab was approved as a monotherapy for patients with microsatellite instability-high recurrent endometrial cancer.
0 comments
Women's Cancer Research Foundation
Oct 5, 20211 min read
Blood Test for Many Cancer Types as Supplement to Screening
The blood test uses next-generation sequencing to analyze the arrangement of circulating cell-free DNA from a blood sample.
0 comments
Women's Cancer Research Foundation
Aug 31, 20212 min read
Women With Ovarian Cancer at Higher Risk for Mental Health Disorders
Ovarian cancer survivors who had a mental health diagnosis demonstrated an 80% higher risk for mortality.
0 comments
Women's Cancer Research Foundation
Aug 12, 20211 min read
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Oral contraceptive use potentially reduces the risk of breast, ovarian, and endometrial cancers.
0 comments
Women's Cancer Research Foundation
Aug 5, 20211 min read
Drug Boosts Survival for Women with Advanced Ovarian Cancer
Lynparza (Olaparib), a targeted cancer therapy, has recently shown a meaningful survival benefit after 5 years.
0 comments
Women's Cancer Research Foundation
Jul 5, 20211 min read
Appropriateness of Specific Chemotherapy Regimens in Elderly Patients Diagnosed with Ovarian Cancer
Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian....
0 comments
Women's Cancer Research Foundation
Jun 30, 20211 min read
Sleep quality and related factors in patients with breast cancer: A cross- sectional study in Taiwan
Researchers studied various factors related to post-treatment sleep disturbances in breast cancer patients.
0 comments
Women's Cancer Research Foundation
Jun 23, 20211 min read
Associations Between Multimorbidity and Depression in Breast Cancer Survivors
Researchers used the UK Biobank (a national biomedical database) to examine the link between multimorbidity and depression.
0 comments
Women's Cancer Research Foundation
Jun 10, 20211 min read
New blood test could reveal undiagnosed ovarian cancer in thousands of women
Researchers have developed a screening test for ovarian cancer that potentially detects the disease at earlier stages.
0 comments
Women's Cancer Research Foundation
Jun 3, 20212 min read
HPV-Related Cancers Are on the Rise
With the Exception of Cervical Cancer, HPV-Related Cancers Are on the Rise, Especially in Older Adults
0 comments
Women's Cancer Research Foundation
May 19, 20211 min read
For Ovarian Cancer Survivors, Exercise Can Lift Spirits
A recent study from the Yale School of Public Health reported that routine exercise may reduce the incidence of depression among ovarian
0 comments
Women's Cancer Research Foundation
May 7, 20211 min read
World Ovarian Cancer Day - Promising Research
May 8th marks World Ovarian Cancer Day, and annually, it's an opportunity to globally embrace solidarity in the fight against ovarian cancer
0 comments
Women's Cancer Research Foundation
Apr 29, 20212 min read
Secondary cytoreduction followed by chemotherapy vs chemotherapy alone
Secondary cytoreduction followed by chemotherapy vs chemotherapy alone in platinum-sensitive relapsed ovarian cancer
0 comments
Women's Cancer Research Foundation
Apr 7, 20212 min read
Endometrial Cancer Risk in Women Diagnosed with a Germline BRCA1 or BRCA2 Mutation
BRCA1 and BRCA2 are genes that produce proteins that help repair damaged DNA (a person’s unique genetic code).
0 comments
bottom of page